{"id":"W2160875391","doi":"10.3747/co.21.1647","title":"Learning Experiences with Sunitinib Continuous Daily Dosing in Patients with Pancreatic Neuroendocrine Tumours","year":2014,"lang":"en","type":"review","venue":"Current Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Sunitinib; Medicine; Everolimus; Dosing; GiST; Tyrosine-kinase inhibitor; Neuroendocrine tumors; Oncology; Renal cell carcinoma; Internal medicine; Vascular endothelial growth factor; Schedule; Clinical trial; Pharmacology; Stromal cell; VEGF receptors; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008042353,0.0003955045,0.0006027535,0.000580043,0.0001505904,0.0003845336,0.0004832897,0.000654588,0.00149832],"category_scores_gemma":[0.001303918,0.0001179152,0.0004279726,0.0005562964,0.0002617822,0.0009543424,0.0004681402,0.0009583073,0.0006248858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002750396,"about_ca_system_score_gemma":0.000355951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004350602,"about_ca_topic_score_gemma":0.001280189,"domain_scores_codex":[0.9998047,0.0000683993,0.00003055213,0.00002817763,0.00005124366,0.00001704988],"domain_scores_gemma":[0.9996294,0.0001965165,0.00006870685,0.000008217248,0.00005638578,0.00004070494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001096099,0.00007345549,0.0006929821,0.004974538,0.000081395,0.0007245524,0.0001928542,0.000256105,0.000891309,0.0007776842,0.01373877,0.9774867],"study_design_scores_gemma":[0.0001855282,0.001008712,0.008439221,0.005881811,0.0002760452,0.02740241,0.0004066448,0.0003007639,0.001798455,0.002274491,0.9519757,0.00005021197],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002261194,0.9928846,0.0003076495,0.001202728,0.0003202858,0.000009912632,0.0000111683,0.000008366472,0.002994138],"genre_scores_gemma":[0.0123772,0.9842701,0.0004114717,0.001004293,0.0007295847,0.00001272962,0.00003909864,0.000002916262,0.001152745],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00149832,"threshold_uncertainty_score":0.005012333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06708898796358823,"score_gpt":0.4121968264952486,"score_spread":0.3451078385316604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}